Search Results 361-370 of 18826 for alzheimers
I have been studying molecular pathogenesis of Alzheimer's disease since 1995, and I also have been testing viral gene therapy since 2005. Why and how did you ...
Last week, the Food and Drug Administration approved aducanumab to treat Alzheimer's disease, which is a progressive brain disorder that is the most common ...
... Alzheimer's disease. Despite concerns regarding mercury in seafood, Martha Clare Morris, lead author of the study at Rush University Medical Center, told ...
Ronald Petersen, director of the Alzheimer's Disease Research Center at Mayo Clinic, says aducanumab targets the amyloid plaques in the brain that are believed ...
With that fundamental role in our health, could mitochondria offer an answer to prevent or reverse the death of brain cells in patients with Alzheimer's disease ...
Blood offers promise as a way to detect Alzheimer's disease at its earliest onset. Mayo Clinic researchers say they envision a test that would detect ...
About 30 Mayo Clinic scientists are presenting at this week's Alzheimer's Association International Conference in Chicago, and another roughly two dozen ...
November is Alzheimer's Disease Awareness Month, a time to raise awareness of the disease while recognizing the important work that caregivers do when caring ...
“By itself, the test identified individuals who were three times more likely to develop cognitive impairment or Alzheimer's disease within three to five years,” ...
Other studies have shown that many people would want to have tests to know if they carry the gene that causes Alzheimer's disease. The new study showed that ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.